Update information
Minor changes since publication
September 2025: Source guidance references were updated in statement 1 to align with changes to NICE's guideline on pancreatic cancer.
December 2024: Under the outcome measure in statement 4, a note was added about supply disruption to pancreatic enzyme replacement therapy and that availability varies.